effectiveness Prepared by: David Pryce & Reshma Kolambkar - - PowerPoint PPT Presentation

effectiveness
SMART_READER_LITE
LIVE PREVIEW

effectiveness Prepared by: David Pryce & Reshma Kolambkar - - PowerPoint PPT Presentation

Diabetes Inpatient Surveillance Dashboard: Evaluation of effectiveness Prepared by: David Pryce & Reshma Kolambkar Business Analytics Services WSLHD Health Data Analytics October 2019 Aim Evaluation of effectiveness of dashboard


slide-1
SLIDE 1

Prepared by: David Pryce & Reshma Kolambkar Business Analytics Services WSLHD

Health Data Analytics October 2019

Diabetes Inpatient Surveillance Dashboard: Evaluation of effectiveness

slide-2
SLIDE 2

Aim

  • Evaluation of effectiveness of dashboard
  • Evaluation of impact on clinical activities
slide-3
SLIDE 3

Introduction

 Western Sydney has a high prevalence of Diabetes.  Testing Diabetes is not a routine in all hospitals in WSLHD.  Mid-2016 - HbA1c Screening tests at Blacktown and Mt. Druitt ED commenced.  Revealed alarming rate

– 17% Diabetes (HbA1c > 6.5 ) – 30% Pre-diabetes (HbA1c 5.7 - 6.4)

 Generating and maintaining an updated list of these individuals was challenging.

slide-4
SLIDE 4

Background

 Diabetes Inpatient Surveillance Dashboard developed  Improve identification of diabetes patients across Hospital  Provide Pop Health view if HbA1c Testing (>100k)  Enable improved management of inpatients by Diabetes Team via MOC

slide-5
SLIDE 5

Data Source

slide-6
SLIDE 6

Dashboard as a tool

slide-7
SLIDE 7
slide-8
SLIDE 8
slide-9
SLIDE 9
slide-10
SLIDE 10
slide-11
SLIDE 11

Evaluation Method

slide-12
SLIDE 12

Quantitative evaluation

 Currently – Length of Stay (LOS) – Reduce in the LOS by ~2days – CMI – No signification improvement  In future, planning to consider HAC for diabetes complication

Clinical Indicators – (Average length of stay in days ) 6 Months Before (05/05/2018 – 04/11/2018) 6 months After (05/11/2018 – 04/05/2019) Comparison Indicator Primary Diagnoses is diabetes - Including Gestational Diabetes 3.93 3.42 0.51 ↓ Primary Diagnoses is diabetes - Excluding Gestational Diabetes 3.93 3.45 0.48 ↓ Identified diabetes in any diagnoses - Including Gestational Diabetes 5.36 4.37 0.99 ↓ Identified diabetes in any diagnoses - excluding Gestational Diabetes 7.19 5.24 1.95 ↓

slide-13
SLIDE 13

Qualitative evaluation

slide-14
SLIDE 14

Qualitative evaluation

slide-15
SLIDE 15

Evaluation Results

 Improved identification diabetes patients  Improved clinical management of hyperglycaemia and hypoglycaemia  Improved identification of undiagnosed diabetes in pregnancy.  Reduce inpatient length of stay  Dashboard helped identifying data quality issues  User feedback - easy review of all diabetes patients across the whole hospital

slide-16
SLIDE 16

Discussion

 Better outcomes via reduced LOS  Need to analyse the Model of Care – to determine Improved evaluation metrics  Usefulness of the dashboard as a tool by end users  Staff are using the dashboard for MOC Operational and research purposes  Some better evaluation metrics could be TAT, Complications, eGFR, measures of Liver/Kidney conditions

slide-17
SLIDE 17

Conclusion

  • The evaluation carried out showed a decrease in the Average

length of stay

  • Feedback from clinician that dashboard helped to quickly identify

patient and provide better care

  • Triangulation of data from different sources can provide a

comprehensive view of diabetes patient journey in hospital.

  • Dashboard enables complex data set to be easily accessed by

clinicians on one platform.

slide-18
SLIDE 18

Thank You to the Project Team

 Project Sponsor – Dr Tien-Ming Hng, Head of Endocrinology Department, Blacktown Mt Druitt Hospitals  BAS Team – Ching Luo (Senior Analyst Developer), Reshma Kolambkar (Senior Business Data Analyst)  BAS Manger – David Pryce

slide-19
SLIDE 19

Feedback/Questions?

slide-20
SLIDE 20

Thank You !!!